News

Antibiotic Use, Resistance and Shared Stewardship White Paper Available Now

To read the 2014 Antibiotics Symposium White Paper go to www.animalagriculture.org.

The 2014 Antibiotics Symposium, developed by the NIAA, was held in Atlanta, Ga. November 12-14, 2014. The symposium was a continuation of discussion and sharing of information from symposiums in 2011, 2012 and 2013.

The 2014 symposium was funded in part by the Beef Checkoff®, U.S. Department of Agriculture Animal and Plant Health Inspection Service – Veterinary Services, United Soybean Board, Indiana Soybean Alliance®, Drovers CattleNetwork, Dairy Herd Management, Bovine Veterinarian, PorkNetwork, Brownfield Ag News – A Division of Learfield, DairyBusiness, Merck Animal Health, Pork Checkoff®, Zoetis™, Farm Bureau Georgia®, American Farm Bureau®, Elanco™, Auburn University – Food Systems Institute, Qiagen®, Vetericyn® and the American Veterinary Medical Association®.

Details coming soon on the 2015 Antibiotics Symposium!

Click Here to read the White Paper now – Specifically see:

http://animalagriculture.org/Resources/Documents/Conf%20-%20Symp/Symposiums/2014%20Antibiotics/2014%20ABX%20White%20Paper.pdf

“In order to address antibiotic stewardship in human and animal practice, we must assure the careful and accountable, use of antibiotics in all settings, decrease the need for antibiotics through prevention, including the development and use of vaccines, increased veterinary oversight, optimum management practices, development and use of rapid diagnostics, development of patient/client stewardship programs with A One Health perspective, and educational programs for doctors [physicians], patients, veterinarians and clients.1”   

“The national strategy for combating antibiotic resistance includes implementing interventions to slow the spread of antibiotic resistant bacteria, improving One Health surveillance, development and application of rapid diagnostics for accurate treatments, new research and development for  therapies and other tools (e.g., new antibiotics, vaccines, etc.), and international collaboration to achieve near real-time information sharing.9”